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Mitochondrial Thioredoxin System 
as a Modulator of Cyclophilin D 
Redox State
Alessandra Folda1, Anna Citta1, Valeria Scalcon1, Tito Calì1, Francesco Zonta3, Guido Scutari1, 
Alberto Bindoli2 & Maria Pia Rigobello1
The mitochondrial thioredoxin system (NADPH, thioredoxin reductase, thioredoxin) is a major redox 
regulator. Here we have investigated the redox correlation between this system and the mitochondrial 
enzyme cyclophilin D. The peptidyl prolyl cis-trans isomerase activity of cyclophilin D was stimulated by 
the thioredoxin system, while it was decreased by cyclosporin A and the thioredoxin reductase inhibitor 
auranofin. The redox state of cyclophilin D, thioredoxin 1 and 2 and peroxiredoxin 3 was measured in 
isolated rat heart mitochondria and in tumor cell lines (CEM-R and HeLa) by redox Western blot analysis 
upon inhibition of thioredoxin reductase with auranofin, arsenic trioxide, 1-chloro-2,4-dinitrobenzene 
or after treatment with hydrogen peroxide. A concomitant oxidation of thioredoxin, peroxiredoxin and 
cyclophilin D was observed, suggesting a redox communication between the thioredoxin system and 
cyclophilin. This correlation was further confirmed by i) co-immunoprecipitation assay of cyclophilin 
D with thioredoxin 2 and peroxiredoxin 3, ii) molecular modeling and iii) depleting thioredoxin 
reductase by siRNA. We conclude that the mitochondrial thioredoxin system controls the redox state of 
cyclophilin D which, in turn, may act as a regulator of several processes including ROS production and 
pro-apoptotic factors release.
Cyclophilins are a family of peptidyl prolyl isomerases able to catalyze the cis-trans isomerization of the peptidyl 
prolyl bonds (PPIase activity)1. CypD, the mitochondrial isoform of the cyclophilin family, is involved in the 
regulation of the mitochondrial permeability transition pore2. Accordingly, mitochondria from CypD−/− mice, 
are more resistant to Ca2+ dependent pore opening or oxidative stress3,4 compared to the wild type. However, 
cyclophilins also act as protective factors against oxidative stress since cardiomyocytes lacking CypA are more 
susceptible to tert-butylhydroperoxide treatment5. Furthermore, overexpression of CypD protects HEK293 cells 
from oxidative stress due to tert-butylhydroperoxide exposure as it is apparent from the longer maintenance of 
the mitochondrial membrane potential6. Lastly, oxygen stress has been shown to increase the expression of cyclo-
philin 18 in rabbit blastocysts7.
Cyclophilins are endowed with redox properties and they are able to interact with both peroxiredoxin and 
thioredoxin. Human T cell cyclophilin 18 was shown to bind to the thiol-specific antioxidant protein Aop1 (Prx3) 
and stimulate its activity8. Prx2 can be reduced by human CypA in a cyclosporin A (CsA)-independent process 
involving Cys-115 and Cys-1619. Chloroplast cyclophilin was shown to be inactive in its oxidized form and reac-
tivated by thioredoxin-m, suggesting that cyclophilin is a definite target of Trx10. Indeed, peptide mass fingerprint 
analysis on plant mitochondria identified a peptidyl prolyl cis-trans isomerase as a target candidate of Trx11. 
Therefore, in the cell, the ability of Trx to reduce cyclophilin indicates the occurrence of an electron flux from Trx 
to cyclophilin also involving peroxiredoxin9,10.
Several observations indicate that cyclophilins are also sensitive to redox conditions. For instance, a 
ROS-dependent mitochondrial permeability transition associated with increased CypD levels and oxidation 
has been shown to occur in fibroblasts from patients with X-linked adrenoleukodistrophy and, notably, treat-
ment with both cyclosporin A and N-acetylcysteine12 prevented such mitochondrial alterations. According to 
Linard et al.13, CypD oxidation affects its conformation and activity suggesting that it could potentially act as a 
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mitochondrial redox sensor. In particular, oxidized CypD could induce mitochondrial permeability transition 
leading to cell necrosis13. The conserved Cys-157 and Cys-203 of CypD act as critical redox-sensitive residues 
and appear crucial for the activation of the mitochondrial permeability transition pore13. The fact that mouse 
liver mitochondria expressing the CypD mutant Cys203Ser were insensitive to Ca2+-induced swelling14 and that 
Cys-203 nitrosylation reduces pore opening in mouse embryonic fibroblasts14 further highlights the critical role 
played by the Cys-203 residue of CypD in inducing mitochondrial permeability transition, possibly through the 
formation of a disulfide bond with Cys-15713.
The thioredoxin system, comprising NADPH, thioredoxin reductase (TrxR) and thioredoxin (Trx), acts by 
transferring electrons from NADPH to Trx, which, in its reduced form, works as an electron donor for peroxire-
doxin (Prx) that, in turn, reduces hydrogen peroxide to water15. Thioredoxin is also an important reducing agent 
for oxidized proteins. Both cytosolic and mitochondrial thioredoxin reductase isoforms possess a C-terminal 
active site containing a selenocysteine residue with a low pKa16, therefore endowed with enhanced nucleophilic-
ity. Consequently, many compounds, including anticancer agents, are considered as effective targets of TrxR17,18 
and, in particular, gold compounds are potent inhibitors of TrxR acting in the nanomolar range19–21.
In the present paper we show that both in cancer cells and in isolated mitochondria, TrxR inhibition leads to a 
change in the redox state of CypD towards a more oxidized form that is potentially responsible for several effects 
including ROS production and enzyme activity modulation.
Results
The thioredoxin system reduces CypD and increases its isomerase activity. Figure 1 shows the 
PPIase activity measured as absorbance increase of p-nitroaniline in a heart mitochondrial matrix fraction incu-
bated under different experimental conditions, while Fig. 1B reports the first order rate constants. Reducing 
conditions, such as the presence of the complete thioredoxin system (NADPH, TrxR and Trx), stimulated the 
rate and extent of PPIase activity. NADPH alone had hardly any effect while auranofin (AF), at concentrations 
Figure 1. PPIase activity of CypD in the mitochondrial matrix. Mitochondrial matrix (30 μg proteins) 
was preincubated in 100 mM NaCl, 50 mM HEPES/Tris (pH 8.0) at 25 °C for 15 min in the presence, where 
indicated, of 300 μM NADPH, 0.4 μM TrxR1, 3 μM Trx from E. coli or 1 μM auranofin (AF). PPIase activity was 
estimated by a coupled assay utilizing α -chymotrypsin as described under Methods. (A) time course of PPIase 
activity in different experimental conditions and (B) first-order rate constants (s−1) indicated in the ordinate 
axis (*p < 0.01) and corresponding to reactions obtained in conditions similar to those of the curves reported in 
(A). Mean ± SD, n = 5 are shown.
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able to inhibit thioredoxin reductase but ineffective on CypD, completely prevented the stimulatory effect on 
PPIase activity elicited by the complete thioredoxin system (Fig. 1B). CsA, a specific inhibitor of cyclophilin D, 
inhibits PPIase activity, as already shown by Nguyen et al.14. Finally, the hydrolytic activity of α -chymotrypsin 
on the peptide N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide was strongly reduced in the absence of mitochondrial 
matrix preparation, while AF, at the concentrations used, did not alter α -chymotrypsin activity (Fig. 1B). Also 
the thiol-oxidizing agent diamide markedly inhibited PPIase activity (data not shown). Therefore, the role of the 
thioredoxin system in maintaining CypD reduced was clearly apparent as reducing and oxidizing conditions 
increased and decreased PPIase activity of CypD, respectively.
Inhibition of the thioredoxin system induces CypD oxidation in isolated mitochondria. First 
of all, the redox state of mitochondrial proteins in isolated mitochondria was examined. In Fig. 2 (A,A′), treat-
ment of isolated heart mitochondria with auranofin, a potent inhibitor of thioredoxin reductase22,23, caused 
Figure 2. Redox Western blot of CypD (A,A′), Trx2 (B) and Prx3 (C) in isolated rat heart mitochondria. 
Aliquots of 200 μg proteins of rat heart mitochondria were incubated under various conditions at 25 °C for 
30 min. (a) control; (b) 2 mM NAC; (c) 2 mM diamide; (d) 1 μM CsA; (e) 5 μM AF; (f) 5 μM AF + 1 μM CsA; (g) 
2 mM H2O2. To determine the redox state of CypD and Trx2, samples, derivatized first with 30 mM IAA and 
then with 10 mM IAM, were subjected to urea-PAGE in non-reducing conditions (A,B). To analyze the redox 
state of Prx3, samples, derivatized with 10 mM AIS, were subjected to SDS-PAGE in non-reducing conditions 
(C). (A′) densitometric analysis of data reported in panel (A) and referred to CypD, and performed using 
ImageJ software. Bands undergoing oxidation are marked by arrows in (A′).
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oxidation of CypD as revealed by the appearance in the redox Western blot of a number of bands compatible 
with the number of thiols present in the enzyme sequence of human CypD13. With isolated rat heart mitochon-
dria at least 5 bands were apparent, indicating the presence of 4 thiols potentially subjected to redox transition. 
Previous observations based on electrophoretic mobility shift or two-dimensional gel electrophoresis showed 
the oxidation of CypD under specific conditions13,24. In isolated mitochondria the redox Western blot per-
formed with the “IAA/IAM” method25–27 (see also Methods) showed the oxidized bands in the upper part of 
the gel. In Fig. 2A,A′, lane a (control) shows the redox condition of CypD reflecting the normal redox metabolic 
state, similar to mitochondria treated with N-acetyl cysteine (NAC) (lane b), while diamide treatment (lane c), 
illustrates a shift to largely oxidized condition. Incubation of mitochondria with CsA alone did not essentially 
modify the redox state of CypD (lane d), whereas auranofin showed a strong increase of intensity of the more 
oxidized bands (lane e). Following TrxR2 inhibition by auranofin, Trx2, turned to a more oxidized form19,20,28,29, 
and this condition is particularly evident when CsA is present together with AF (Fig. 2B, lane f). Regarding 
oxidation of Trx2 (Fig. 2B), three major bands were detected in accordance with the presence of only two active 
site cysteines30 in Trx2. Also peroxiredoxin, a major substrate of thioredoxin, was found oxidized (dimer) after 
inhibition of thioredoxin reductase by auranofin (Fig. 2C, lane e) as already demonstrated by Cox et al.31. The 
presence of CsA increases the effect of auranofin (Fig. 2C, lane f). In lane g the oxidizing effect of H2O2 on the 
examined enzymes is reported. Notably, addition of H2O2 alone led to an oxidation pattern comparable to that 
observed with auranofin. Therefore, the oxidation of CypD in mitochondria incubated with either auranofin or 
H2O2 appears consistent with that of Trx2 and Prx3, suggesting a redox interplay between the thioredoxin system, 
peroxiredoxin and CypD.
ROS production in isolated mitochondria treated with CsA and auranofin. As ROS, and specif-
ically H2O2 formation, are indicative of a redox imbalance leading to oxidation of the thiol enzymes involved in 
mitochondrial redox signaling (Trx2/Prx3/CypD), the effect of CsA on ROS production by isolated mitochon-
dria was examined. Treatment of mitochondria with CsA induced a moderate increase in the amount of H2O2 as 
assessed by both Amplex Red oxidation (A) and DHR fluorescence decrease (B) (Fig. 3). A further increase of 
H2O2 level was observed upon inhibition of TrxR2 with a low dose of auranofin, a condition which prevented the 
removal of hydrogen peroxide as the electron flow to Prx3 was inhibited. The presence of CsA, which binds to 
CypD, markedly stimulated the production of ROS (about 30%) induced by auranofin in mitochondria.
Thioredoxin system inhibition determines the oxidation of CypD in tumor cell lines. Alteration 
of the redox conditions may trigger death of tumor cell lines20. Therefore, the redox states of cytosolic and mito-
chondrial Trxs, Prx3 and CypD in CEM-R cancer cells incubated with NAC, auranofin, arsenic trioxide (ATO), 
1-chloro-2,4-dinitrobenzene (CDNB) and the oxidants diamide and hydrogen peroxide were compared. Trxs 
and CypD were analyzed by using a modified redox Western blot “IAM/IAA”32 (see also Methods) in which the 
upper band represents the fully reduced enzyme, the lowest represent the completely oxidized form, while the 
intermediate bands represent the formation of disulfides, mixed disulfides with glutathione or protein thiols, or 
nitrosylated forms. This distribution of different redox states was clearly shown for cytosolic and mitochondrial 
thioredoxin30. As shown in Fig. 4 (lane b), NAC did not substantially change the redox state of CypD, Trxs and 
Prx 3. In contrast, with the oxidizing agents diamide (lane c), auranofin (lane d) and hydrogen peroxide (lane e), 
CypD clearly underwent increased oxidation, with bands appearing in the lower part of the gel (Fig. 4A). In simi-
lar oxidizing conditions, both cytosolic and mitochondrial thioredoxins underwent to oxidation (Fig. 4B–D) and 
also Prx3 was in the oxidized form (dimer) (Fig. 4C). In particular, Trx1 exhibited 6 major bands (Fig. 4D) related 
to the different redox conditions of the five cysteine residues contained in the protein and, at the same time, 
Trx2 showed three major bands (Fig. 4B)26,30,32. Trx2 was almost completely oxidized indicating that it is more 
easily oxidized in comparison to its cytosolic isoform33. In addition to auranofin, other inhibitors of thioredoxin 
Figure 3. H2O2 formation in isolated rat heart mitochondria incubated with different concentrations of 
auranofin in the presence or absence of CsA. Mitochondria (100 μg proteins) were incubated in 100 mM 
sucrose, 50 mM KCl, 20 mM HEPES/Tris (pH 7.4), 0.5 mM Na,K-phosphate, 5 mM succinate with the 
indicated concentrations of auranofin and, when present, 5 μM CsA. ROS production was followed using the 
fluorescent probes Amplex Red (A) or DHR (B) as described in Methods. The values are the means ± SD of five 
measurements (***p < 0.001 referred to the respective control).
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reductase such as ATO and CDNB34,35 were tested in CEM-R cells to evaluate the changes of the redox state of 
CypD, Trxs, and Prx3. As apparent in Fig. 4 (lanes f and g) both ATO and CDNB led to an oxidation of these 
redox proteins. In particular, CDNB gave results very similar to those obtained with auranofin, while ATO was 
less effective. Similar results for CypD, Trx2 and Trx1 redox state were found using a different cell line such as 
HeLa cells (see Supplementary Fig. S1 online). Different concentrations of auranofin or other inhibitors were 
used in accordance with the amount of thioredoxin reductase present in each cell line. For instance, in HeLa cells 
the level of thioredoxin reductase is higher than that of other cells36. Therefore, in cancer cells, upon induction of 
oxidizing conditions, there is a concurrent oxidation of Trxs, Prx and CypD. Knockdown of TrxR2 in HeLa cells 
(see Supplementary Fig. S2 online), although only partial, caused an oxidation of Trx2 and a concomitant moder-
ate oxidation of CypD, again showing a link between mitochondrial thioredoxin system and CypD.
Interaction of CypD with Trx2 and Prx3: co-immunoprecipitation. In Fig. 5 (A,A′) the comparative 
estimation in heart and liver mitochondrial matrix of the relative amount of CypD, Trx2 and Prx3 is reported. As 
shown, the three enzymes are more abundant in the heart than in the liver.
As previously reported, upon inhibition of the thioredoxin system, CypD changes its redox state. Therefore, 
the interaction of CypD with proteins belonging to the thioredoxin system was studied in rat heart mitochondrial 
matrix. Fig. 5 (panel B) shows that CypD co-immunoprecipitated with Trx2 when proteins from mitochondrial 
matrix were immunoprecipitated with a Trx2 antibody and then immunoprobed with a CypD antibody. Similar 
results were obtained with mitochondrial matrix proteins using a Prx3 co-immunoprecipitation (Fig. 5, panel C). 
Figure 4. Redox Western blot of CypD, Trx1, Trx2 and Prx3 in CEM-R cells. CEM-R cells (1 × 106), 
treated for 18 h in various conditions, were derivatized with 10 mM IAM and then with 30 mM IAA for the 
determination of redox state of CypD, Trx1, Trx2 using urea-PAGE in non-reducing conditions (A–D). For the 
estimation of the redox state of Prx3, cell lysates were derivatized with 10 mM AIS and subjected to SDS-PAGE 
in non-reducing conditions (C). (a) control; (b) 2 mM NAC; (c) 2 mM diamide, (d) 3 μM AF; (e) 1 mM H2O2;  
(f) 15 μM ATO; (g) 20 μM CDNB.
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In this case, the co-immunoprecipitation shows that Prx3 and CypD can physiologically interact, consistent with 
a functional relationship linking these proteins.
In addition, to confirm these results, co-immunoprecipitation was also performed utilizing an anti-CypD 
antibody to detect Trx2 and Prx3 in the pull down. The results reported in Fig. S3 online, show that there was a 
coherent connection between the proteins of interest.
Molecular modelling of the interaction of CypD with Prx3 and Trx2. In order to further explore the 
nature of the interactions between CypD and Trx2 or Prx3, we performed a molecular docking prediction using 
ClusPro 2.0 webserver37. The results are described below and summarized in legend to Fig. 6. In both cases, the 
great majority of possible docking configurations involve the hydrophobic binding site of CsA to CypD and aro-
matic residues in Trx2 and Prx3. These kinds of hydrophobic interactions stabilize the overall structure of protein 
and protein complexes, and can thus explain in principle the co-immunoprecipitation we have experimentally 
observed.
CypD – Prx3 interaction. The great majority of possible predicted interactions between CypD and Prx3 
(87%), involves the CsA binding site of CypD. In the most probable binding configuration, Prx3 interacts with the 
hydrophobic pocket of CypD, in particular with residues Ala-143 and Phe-155, through its Phe-107 (Fig. 6, Panels 
A and B), and its further stabilized by the formation of the salt bridges showed in Fig. 6 Panel C. Remarkably, 
this interaction further buries the catalytic Cys-157. The other predicted interactions share similar features, but 
involve other two phenylalanine residues of Prx3 namely Phe-139 or Phe-222, resulting in different orientation 
of Prx3 with respect to CypD. Altogether, these results suggest that binding is driven by hydrophobic interaction, 
and it is facilitated by the presence of exposed hydrophobic side chains in the Prx3 molecule.
CypD – Trx2 interaction. Similarly to the previously described interaction between CypD and Prx3, also in 
this case, the great majority of possible bindings (96%) involve the CypD hydrophobic region that is responsible 
for the binding of CsA. However, in this case, the only accessible aromatic residue is Trp-89, and thus most of 
the possible binding presents similar mutual orientation between the two molecules. Also in this case, formation 
of salt bridges help to stabilize the interaction. In the most probable configuration, the proximity of Arg-193 of 
CypD with Asp-120 of Trx2, and that of Lys-190 of CypD with Asp-66 and Asp-123 of Trx2, suggests that they can 
be involved in the formation of such bridges as shown in Fig. 6, panel F.
Discussion
Treatment with auranofin, or other recognized inhibitors of thioredoxin reductase such as ATO and CDNB, 
induced a change of Trx2, Prx3 and CypD thiol redox state in isolated mitochondria and cultured tumor cells 
(Figs 2 and 4). A shift towards an oxidized state of CypD was also observed in the presence of the thiol-oxidizing 
agent diamide, which directly acts on protein dithiols located in close proximity, or with H2O2 that in the redox 
signaling processes is considered to function as a second messenger by rapidly reacting with peroxiredoxins 
Figure 5. Comparative estimation of CypD, Trx2 and Prx3 in rat liver (L) and heart (H) mitochondrial matrix 
(A,A′). Co-immunoprecipitation of CypD with Trx2 (B) and Prx3 (C). A: comparison of CypD, Trx2 and 
Prx3 content between liver (L) and heart (H) mitochondrial matrix. Mitochondrial matrix preparations (40 μg 
protein of each) were analyzed by Western blotting. (A′) densitometric analysis of data reported in panel  
(A). (B,C) pre-reduced rat heart mitochondrial matrix (200 μg protein), was incubated with antibodies anti-
Trx2 or anti-Prx3, as described in Methods. The pull down from the immunoprecipitation was separated by 
SDS-PAGE, blotted and probed with monoclonal anti-CypD. IB: immunoblot. (B) co-immunoprecipitation of 
CypD with Trx2; (C) co-immunoprecipitation of CypD with Prx3 with the respective controls. (a) aliquot of 
heart mitochondrial matrix (10 μg protein); (b) aliquot of supernatant (8 μL) after immunoprecipitation.
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which, in turn, may act as sensors of this oxidant38. Finally, depletion of TrxR2 with siRNA led to a partial oxi-
dation of CypD concomitant with oxidation of Trx2 (Fig. S2 online). There are several recent reports suggest-
ing an involvement of cyclophilins in redox regulated processes12,24,39,40. In X-linked adrenoleukodystrophy, an 
increased expression and oxidation of CypD in fibroblasts was observed12. S-glutathionylation of CypD was also 
seen in mitochondria isolated from the heart after tachycardia, a condition increasing the oxidation state of the 
cardiac tissue24. Also, cyclophilin A was shown to undergo glutathionylation in cells treated with chloramines and 
hypochlorous acid, further underlining its role as a redox regulatory protein40. Of note, in chloroplasts, cyclophi-
lin 20–3, is reduced and activated by Trx, which, in turn, is maintained reduced by light. Cyclophilin 20–3 can be 
oxidized by H2O2/peroxiredoxin B39 regulating the cysteine biosynthesis system.
Cyclophilin D plays a major role in controlling the mitochondrial membrane permeability transition 
pore41. The peptidyl prolyl cis-trans isomerase activity of CypD in the mitochondrial matrix of liver and heart 
mitochondria was assessed by Halestrap and Davidson and shown to be sensitive to CsA and correlate with 
calcium-induced swelling42. According to our data, CypD can transduce the redox state to components of the 
mitochondrial membrane and hence influence its permeability conditions. Auranofin, a well known inhibitor 
of TrxR22,23 was previously shown to strongly stimulate the mitochondrial membrane permeability transition23. 
Here we have shown that inhibition of TrxR is responsible for the increased oxidation of CypD. Consequently, the 
permeability transition pore can be potentially regulated by the redox conditions of CypD which, in its oxidized 
state, can lead to pore opening while the reverse takes place when CypD is reduced. Of note, CsA which binds 
to CypD and makes the system similar to the CypD null cells3,4 does not influence the redox state of CypD. The 
mitochondrial permeability transition pore is composed of several proteins, but CypD represents the most critical 
Figure 6. Binding configuration for CypD and Prx3 or Trx2. Panels (A–C) show the best predicted binding 
of CypD and Prx3. Panel (A) is the global view of the best binding. Panel (B) shows the details of the pocket and 
one can notice the protrusion of Phe-107 of Prx3 in the hydrophobic pocket of CypD and also are highlighted 
the residues of CypD that interact with it. Cys-157 of CypD is shown in green while Cys-109 of Prx3 is shown in 
orange. Panel (C) highlights the possible salt bridges formed by the two molecules, in particular those formed 
by Asp-104 and Asp-136 of Prx3 with Lys-167 of CypD. Panels (D–F) show the binding of CypD to Trx2. Panel 
(D) is the global view of the best predicted binding. As one can see in Panel (E), the interaction of Trp-89 with 
the hydrophobic pocket is more superficial compared to that of Prx3. The position of Cys-157 of CypD is shown 
in green, while Cys-90 and Cys-93 of Trx2 are shown in purple. In Panel (F), the possible salt bridges that could 
stabilize the interaction between the two proteins are reported: Arg-97 of CypD with Asp-120 of Trx2, and Lys-
190 of CypD with Asp-66 or Asp-123 of Trx2. The amino acids residues are labelled according to full-length 
proteins sequence.
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regulatory element41. Conditions leading to inhibition of PTP opening are the lack of CypD3,4, the presence of 
CsA which prevents the binding of CypD to the mitochondrial components of the PTP located to the inner 
membrane2 and any condition preventing the formation of disulfide groups such as treatment with monothiol 
reagents40, nitrosylation of Cys-203 and mutation of Cys-203 to serine14. All these conditions suggest a redox role 
of CypD in controlling the oxidation state of specific mitochondrial membrane components43.
The effect of CsA which, particularly in the presence of AF, leads to a larger production of ROS, suggests that the 
preservation of membrane integrity and, consequently, of the electron transport carriers, might be responsible of 
the increased detection of these species (Fig. 3) that may concentrate inside the mitochondrion and subsequently 
can be released to the cytosol through the aquaporin channel proteins44. Furthermore, the donors of reducing 
equivalents, necessary for ROS production, do not leak out in CsA-treated mitochondria. These results are con-
sistent with previous observations showing that CsA increases ROS formation and lipoperoxidation in cells45–47.
The interaction of CypD with Trx2 and Prx3 was also investigated by co-immunoprecipitation and molec-
ular docking analysis. Most cyclophilins are endowed with highly conserved amino acid patch forming the 
CSA-binding domain (CsA-BD). The opposite side of CsA-BD constitutes the “backface” of CypD which seems 
to mediate the binding to target proteins48. For instance, CypD can dock to phosphate carrier either from the 
“backface” or from the CsA-binding domain49. Further, the interaction between CypD and p53 was shown 
to be CsA dependent50 indicating a docking of CsA-BD to a specific region of p53. We observed that CypD 
co-immunoprecipitated with Prx3 and Trx2 (Fig. 5 and Fig. S3). To better understand this observation, we also 
performed an in silico docking simulation to predict the orientation of the CypD binding to the other two pro-
teins. As apparent in Fig. 6, the majority of the possible predicted interactions (87% for Prx3 and 96% for Trx2) 
show an involvement of the hydrophobic region of CypD, in close proximity to the site of CsA binding. Of note, 
Cys-90 of Trx2, located in a flexible loop, is close to Cys-157 of CypD.
In conclusion, our data suggest that the mitochondrial thioredoxin system is involved in a specific redox 
signaling process, where the thiol redox changes can be transmitted to CypD, and presumably further conveyed 
to several targets such as ATP synthase, ANT, Pi carrier, Bcl2, p53, which are all endowed with redox-sensitive 
thiols50–55. Oxidation of CypD may be due to the action of peroxiredoxin in the presence of hydrogen peroxide, 
while thioredoxin or other reducing factors may reverse the process. Considering the importance of CypD as the 
unique recognized factor in the permeability of the mitochondrial membranes, the redox control dependent on 
the thioredoxin system appears critical for mitochondrial and cellular functioning.
Methods
Preparation of mitochondria and mitochondrial matrix. Rat heart mitochondria were isolated by dif-
ferential centrifugation following the method of Lindenmayer et al.56. Mitochondrial matrix was obtained by son-
ication (twice for 30 s each) of a mitochondrial suspension of about 20 mg/ml protein diluted (1:4) with 25 mM 
Tris/HCl (pH 8.0), followed by centrifugation at 10,000 g. Pellet was discarded and the supernatant centrifuged at 
105,000 g for 30 min in order to separate sub-mitochondrial particles from the mitochondrial matrix. The latter 
was dialyzed overnight against a buffer containing 10 mM Tris/HCl (pH 7.4) and 1 mM EDTA.
Animal (albino rat Wistar) care and relative experimentation were performed in accordance with European 
and Italian laws (D.L. 26/2014) concerning animal used for scientific purposes. All the protocols were approved 
by Ethical Committee of University of Padova and all the animals are from an internal animal house authorized 
by the Ministry of Health (N. 102/2004-A).
Estimation of peptidyl prolyl cis-trans isomerase (PPIase) activity in rat heart mitochon-
drial matrix. PPIase activity was estimated essentially as described by Kofron et al.57 with modifica-
tions. Assays were performed at 5.5 °C in 100 mM NaCl and 50 mM HEPES/Tris (pH 8.0). The peptide 
N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Sigma-Aldrich, St. Louis, MO, USA) was dissolved (3 mM) in tri-
fluoroethanol containing 470 mM LiCl, while 2.4 mM α -chymotrypsin (Sigma-Aldrich) was dissolved in 1 mM 
HCl. Aliquots of mitochondrial matrix (30 μg protein) were preincubated for 15 min in a volume of 50 μl in 
various conditions as indicated in Fig. 1. The assay was performed in a final volume of 500 μl by the addition, 
after 5 min of equilibration, of α -chymotrypsin (48 μM, final conc) followed, after 1 min, by the peptide sub-
strate (60 μM, final conc). The reaction was followed spectrophotometrically at 390 nm as absorbance increase 
of p-nitronaniline resulting from the enzymatic cleavage by α -chymotrypsin of the peptide in the trans form. 
The acquired data were fitted to a first-order rate equation in order to obtain the corresponding rate constants 
(kobs, s−1)10,13,14.
Thioredoxin reductase preparation. Highly purified cytosolic thioredoxin reductase (TrxR1) was 
obtained from rat liver following the procedure of Luthman and Holmgren58. Protein content was assayed with 
the Lowry et al. procedure59.
Western blot of mitochondrial matrix for the detection of CypD, Trx2 and Prx3. Aliquots of 40 μg 
protein of rat liver and heart mitochondrial matrix were loaded onto Bis-Tris Gel NuPAGE (12%) (Novex, Life 
Technology, Carlsbad, CA, USA) in non-reducing conditions, and then subjected to immunoblot detection with 
Trx2 polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), Prx3 monoclonal antibody 
(Abfrontier, Young In Frontier co., Seoul, South Korea) and CypD monoclonal antibody (Calbiochem, Merck 
KGaA, Darmstadt, Germany).
Determination of ROS production in isolated rat heart mitochondria. Rat heart mitochondria 
(0.4 mg/ml protein) were incubated at 25 °C in a 96-well plate with 100 mM sucrose, 50 mM KCl, 0.5 mM Na,K-Pi, 
20 mM HEPES/Tris (pH 7.4) containing 5 mM succinate and, when indicated, 5 μM CsA. Formation of hydrogen 
peroxide was detected by using the fluorogenic probe Amplex Red (Invitrogen, Life Technology) at 20 μM in the 
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presence of 11 nM HRP (λ Ex = 544 nm, λ Em = 620 nm) and 5 μM dihydrorhodamine 123 (DHR) (λ Ex = 500 nm, 
λ Em = 536 nm), using a dual wavelength program with Fluoroskan Ascent FL detector (Labsystems, Finland).
Cell culture. Leukemic lymphoid CEM-R cells, resistant to vinblastine, were cultured in complete RPMI-1640 
medium. Human epithelioid cervix carcinoma HeLa cells were cultured in complete DMEM medium with high 
glucose.
Estimation of the redox state of thioredoxins, CypD and Prx3 in mitochondria and tumor 
cells. The redox state of proteins obtained from isolated mitochondria was estimated following described pro-
cedures25–27. Briefly, 200 μg protein of freshly prepared mitochondria were incubated in 220 mM mannitol, 70 mM 
sucrose, 1 mM EDTA, 5 mM HEPES/Tris (pH 7.4), 5 mM glutamate, 5 mM malate in a final volume of 50 μl under 
different experimental conditions. At the end of incubation time, 100 μl of 11 M urea, 50 mM Tris/HCl (pH 8.3) 
and 1 mM EDTA containing 30 mM iodoacetic acid (IAA) were added and the reaction was carried out for 30 min 
at 37 °C, followed by centrifugation. Then, mitochondrial lysates were precipitated by ice-cold acetone-1 M HCl 
(98:2, v/v). The obtained pellets were washed twice with ice-cold acetone-1 M HCl-H2O (98:2:10, v/v/v), resus-
pended in 60 μL of urea buffer (8 M urea, 50 mM Tris/HCl (pH 8.3) and 1 mM EDTA) with 3.5 mM DTT and 
incubated for 30 min at 37 °C. Thereafter, samples were treated with 10 mM iodoacetamide (IAM), for 20 min 
at 37 °C. After protein determination59, samples were loaded onto urea-PAGE electrophoresis (7 M urea and 7% 
acrylamide) in non-reducing conditions and subjected to Western blot detection. With this procedure (“IAA/
IAM”) the more oxidized bands appear in the upper part of the blotting gel.
In cells, the protein redox state was estimated by redox Western blot according to the described procedures25,27 
as modified by Du et al.32. Briefly, cells incubated under different conditions, were treated with 150 μl of 10 mM 
IAM dissolved in urea lysis buffer (8 M urea, 50 mM Tris/HCl (pH 8.3) and 1 mM EDTA), for 30 min at 37 °C in 
order to alkylate protein thiol groups. Samples were centrifuged at 14,000 g for 1 min and the resulting superna-
tant was treated with 10 volumes of cold acetone-1 M HCl (98:2, v/v) and washed with cold acetone-1 M HCl- 
H2O (98:2:10, v/v/v) followed by centrifugation. The pellet was resuspended in 50 μl of urea lysis buffer containing 
3.5 mM DTT and incubated for 30 min at 37 °C. After incubation, 30 mM IAA was added and the alkylation 
reaction carried out for 30 min at 37 °C. After estimation of protein content59, samples were then subjected to 
urea-PAGE electrophoresis (7 M urea and 7% acrylamide) in non-reducing conditions and blotted. With this 
modified procedure (“IAM/IAA”) the more oxidized bands are found in the lower part of the gel.
For Prx3 redox state estimation the procedure of Stanley et al.60, with modification, was followed. Cells were 
centrifuged at 500 g for 5 min, washed with cold PBS and then treated with 1 ml of 10% trichloroacetic acid. 
Samples, kept at 4 °C for 30 min, centrifuged at 10,000 g for 10 min at 4 °C, were resuspended in 0.5 ml of ice-cold 
acetone, for 10 min and centrifuged again at 10,000 g for 10 min at room temperature (23–26 °C). After removing 
the excess of acetone, the pellet was dissolved in 670 mM Tris/HCl (pH 7.5), 2% SDS and 1 mM EDTA containing 
10 mM AIS (4-acetamido-4′ -((iodoacetyl) amino)stilbene-2,2′ -disulfonic acid) (Invitrogen, Life Technology). 
Derivatization lasted 20 min at room temperature, followed by further 45 min at 37 °C. Samples were loaded, 
without reducing agents, onto Bis-Tris Gel NuPAGE (12%) and blotted. To assess the redox state of Prx3, a Prx3 
monoclonal antibody (Abfrontier, Young In Frontier co.) was used. Rat heart mitochondria (200 μg protein) were 
processed in the same manner, after incubation under various conditions as reported above.
Mitochondrial thioredoxin reductase silencing. HeLa cells were seeded at 50% confluence in 6-well 
plates and transfected with 40–80 nM TXNRD2 siRNA (si GENOME human, Dharmacon, GE Healthcare, Little 
Chalfont, U.K.) using Attractene (Qiagen, Venlo, The Netherlands) as transfection reagent. Medium was replaced 
after 6 h and cells were harvested 48 h after transfection. To determine mitochondrial thioredoxin reductase level, 
cells were lysed in the presence of modified RIPA buffer29 and 25 μg proteins were subjected to SDS-PAGE and 
then to Western blot analysis using monoclonal anti-TrxR2 antibody (SC-166259 Santa Cruz Biotechnology, 
Inc.). For the loading control anti-GAPDH (Santa Cruz Biotechnology, Inc.) was employed. HeLa cells treated 
with TXNRD2 siRNA, under the same conditions described above were subjected to IAM/IAA derivatization to 
determine the redox state of the proteins of interest.
Co-immunoprecipitation of CypD with Trx2 and Prx3. Rat heart mitochondrial matrix (200 μg pro-
tein) was pre-reduced for 30 min at 37 °C in 50 mM Tris/HCl (pH 7.4) in the presence of 0.8 μM TrxR1, 315 μM 
NADPH and 1 mM EDTA in a final volume of 50 μl. The sample was diluted in 50 mM Tris/HCl (pH 7.4), 50 mM 
NaCl, 1 mM NaF, 5 mM EDTA and a protease inhibitor cocktail (Complete, Roche, Mannheim, Germany) con-
taining 0.1 mM PMSF. Pre-clearing phase was performed using 20 μl of protein A/G PLUS-Agarose (Santa Cruz 
Biotechnology, Inc.) for 45 min at 4 °C with stirring. Pre-cleared mitochondrial matrix was centrifuged at 720 g for 
5 min and the supernatant was incubated with Trx2 monoclonal antibody (Abfrontier, Young In Frontier co.) or 
Prx3 monoclonal antibody (Santa Cruz Biotechnology, Inc.) at 4 °C for 2 hours. Slurry of A/G PLUS-Agarose (20μl) 
was added to the mitochondrial matrix, incubated for 1 h at 4 °C, centrifuged at 720 g for 5 min and washed with 
ice-cold RIPA buffer modified, and then with 50 mM Tris/HCl (pH 7.4), 1 mM EDTA, 1 mM NaF and a protease 
inhibitor cocktail (Complete, Roche). The pull down was resuspended in SDS loading buffer containing 100 mM 
DTT, boiled for 10 min, and then centrifuged at 17,000 g for 1 min. The supernatant was separated by SDS-PAGE 
(Mini-PROTEAN® TGX, any kD, Bio-Rad Lab. Inc., Hercules, CA, USA), transferred onto a nitrocellulose mem-
brane using Trans-Blot® Turbo Blotting System (Bio-Rad Lab Inc.). Membrane blots were probed with Trx2 pol-
yclonal antibody (Santa Cruz Biotechnology, Inc.), Prx3 monoclonal antibody (Abfrontier, Young In Frontier 
Co.), CypD monoclonal antibody (Calbiochem, Merck KGaA) and visualized by enhanced chemiluminescence. 
Mitochondrial matrix (10% of initial volume) was also loaded as an input control. In addition, similar experiment 
was performed utilizing an anti-CypD antibody to co-immunoprecipitate Trx2 and Prx3, using the same procedure.
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Molecular modelling of the interaction between CypD and Prx3 or Trx2. A molecular docking 
prediction using ClusPro 2.0 webserver37 was utilized. For CypD, Prx3, and Trx2 the protein structures present 
in PDB (Protein Data Bank), 2bit (human CypD), 1zye (bovine Prx3) and 1uvz (human Trx2) respectively were 
utilized. For Prx3, 1zye crystal structure that presents more than 88.8% identity with human sequence, was used.
Statistical Analysis. Statistical analysis was done using GraphPad Instat, GraphPad Software, Inc. All the 
values are the means ± SD of at least five measurements. Multiple comparisons were made by one-way analysis of 
variance followed by Tukey-Kramer multiple comparison test.
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